Patents by Inventor Eric A. Kitas

Eric A. Kitas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070281979
    Abstract: Compounds of formula as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R3 have the significance given in the application and which can be used in the form of pharmaceutical compositions.
    Type: Application
    Filed: May 30, 2007
    Publication date: December 6, 2007
    Inventors: Marcel Gubler, Wolfgang Haap, Paul Hebeisen, Eric A. Kitas, Bernd Kuhn, Rudolf E. Minder, Brigitte Schott, Hans P. Wessel
  • Publication number: 20070037789
    Abstract: The invention relates to compounds of general formula wherein R1, R2, R3/R3?, R4/R4? and R5/R5? are as defined in the specification and to pharmaceutically acceptable acid addition salts, optically pure enantiomers, racemates or diastereomeric mixtures thereof. The compounds are ?-secretase inhibitors which can be useful in the treatment of Alzheimer's disease or common cancers including, but not limited to, cervical carcinomas and breast carcinomas and malignancies of the hematopoietic system.
    Type: Application
    Filed: August 8, 2006
    Publication date: February 15, 2007
    Inventors: Alexander Flohr, Guido Galley, Roland Jakob-Roetne, Eric Kitas, Wolfgang Wostl
  • Publication number: 20060073522
    Abstract: The present invention relates to a fluorescently labeled growth hormone secretagogue which can be used for the identification of compounds capable of binding to growth hormone secretagogue receptors, in particular by high throughput screening.
    Type: Application
    Filed: December 12, 2005
    Publication date: April 6, 2006
    Inventors: Thilo Enderle, Martin Graf, Cornelia Hertel, Sannah Zoffmann, Eric Kitas
  • Publication number: 20060014945
    Abstract: The invention relates to compounds of the general formula in which R1, R2, R3, R4, R2?, R3?, R4?, R5, and X is —CHR— are as defined in the specification. The invention also provides pharmaceutically acceptable acid addition salts, optically pure enantiomers, racemates and diastereomeric mixtures of such compounds. The invention further provides methods for the treatment of Alzheimer's disease or common cancers.
    Type: Application
    Filed: July 12, 2005
    Publication date: January 19, 2006
    Inventors: Guido Galley, Eric Kitas, Roland Jakob-Roetne
  • Publication number: 20050085421
    Abstract: The present invention relates to a fluorescently labeled growth hormone secretagogue which can be used for the identification of compounds capable of binding to growth hormone secretagogue receptors, in particular by high throughput screening.
    Type: Application
    Filed: October 14, 2004
    Publication date: April 21, 2005
    Inventors: Thilo Enderle, Martin Graf, Cornelia Hertel, Sannah Zoffmann, Eric Kitas
  • Publication number: 20050075327
    Abstract: The present invention provides compounds of the general formula wherein R4 is one of the following groups and R1, R2, R3, R7, R8, and R9 are as defined in the specification and pharmaceutically acceptable salts, optically pure enantiomers, racemates or diastereomeric mixtures thereof. The compounds are useful for the treatment of Alzheimer's disease.
    Type: Application
    Filed: September 27, 2004
    Publication date: April 7, 2005
    Inventors: Alexander Flohr, Guido Galley, Roland Jakob-Roetne, Eric Kitas, Jens-Uwe Peters, Wolfgang Wostl
  • Publication number: 20050054633
    Abstract: The invention relates to malonamide derivatives of formula wherein each of the variables are as defined herein and to pharmaceutically acceptable acid addition salts, optically pure enantiomers, racemates and diastereomeric mixtures thereof. These compounds are ?-secretase inhibitors and may be used for the treatment of Alzheimer's disease.
    Type: Application
    Filed: September 2, 2004
    Publication date: March 10, 2005
    Inventors: Alexander Flohr, Guido Galley, Roland Jakob-Roetne, Eric Kitas, Jens-Uwe Peters, Wolfgang Wostl
  • Publication number: 20020040048
    Abstract: The present invention relates to a pyrrolidine compound and pharmaceutically acceptable esters and/or salts thereof. The compounds are useful as inhibitors of metalloproteases, e.g. zinc proteases, particularly zinc hydrolases, and which are effective in treating disease states are associated with vasoconstriction of increasing occurrences.
    Type: Application
    Filed: July 6, 2001
    Publication date: April 4, 2002
    Inventors: Johannes Aebi, Henrietta Dehmlow, Eric A. Kitas